医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Gavi, NEC, and Simprints to Deploy World’s First Scalable Child Fingerprint Identification Solution to Boost Immunization in Developing Countries

2019年06月06日 PM02:15
このエントリーをはてなブックマークに追加


 

TOKYO

Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on the use of biometrics to improve immunization coverage in developing countries.

Despite enormous progress over the past two decades, there are still approximately 20 million children (*1) who do not receive a basic course of vaccines worldwide, leaving them exposed to some of the world’s deadliest diseases.

One key cause is the fact that only half of all children under 5 in sub-Saharan Africa are currently registered at birth, leaving many without an official identity. This makes it difficult for health practitioners to ensure these infants get the vaccines they need at the right time.

Guided by Gavi’s experience and expertise in immunization, this new project will combine Simprints’ biometric fingerprint technology and NEC’s reinforced authentication engine to help create digital identities for children 1-5 years of age and boost immunization coverage in developing countries.

This new partnership will deploy the world’s first scalable fingerprint identification solution to give children aged 1-5 a digital ID linked to an accurate, complete medical record. All biometric records will be stored securely by Simprints, a UK-based non-profit social enterprise, after caregivers give informed consent to taking their children’s biometric data.

Implementing this plan with conventional extraction and matching engines would be very challenging, since young children’s fingerprints tend to be blurred due to their softness. NEC’s fingerprint authentication engine has overcome this issue, with optimization for infant fingerprints and the use of fingerprint images taken with Simprints scanners. This combination has resulted in highly accurate authentication, with a certification rate of 99% (*2).

The three partners will begin carrying out proof of concept validation of the technology in Bangladesh and Tanzania by early 2020. If successful, the project will then progress to linking children’s digital identity with their vaccination record, helping health practitioners to track which children need to be vaccinated and when.

To date, Gavi has contributed to the immunization of over 700 million children in the world’s poorest countries, and an estimated 10 million lives have been saved.

This initiative helps to promote the 17 Sustainable Development Goals (SDGs) established by the United Nations.

https://www.nec.com/en/press/201906/global_20190606_01.html

 
(*1)   Source: Gavi, the Vaccine Alliance

https://www.gavi.org/about/value/health-equity/

(*2) According to NEC research
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20190605006063/en/

CONTACT

NEC Corporation
Joseph Jasper
Corporate Communications
Division
j-jasper(at)ax.jp.nec.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • City of Hope与Israelita Albert Einstein签署协议以推动拉美地区的癌症治疗
  • Humanigen Announces Closing of Public Offering of Common Stock
  • Masimo O3®を使用してCOVID-19患者の脳酸素化に及ぼす換気補助療法の影響を追究した研究
  • CoVIg-19プラズマ・アライアンス、COVID-19治療薬候補の高度免疫グロブリン製剤を評価するためにNIHが実施した臨床試験のトップライン結果を発表
  • CoVIg-19血浆联盟公布NIH发起的在研药物COVID-19超免疫球蛋白临床试验的顶线结果